Lumos Diagnostics provides point-of-care diagnostic solutions enabling healthcare professionals to diagnose conditions accurately.
Lumos Diagnostics has raised $20.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Lumos Diagnostics's investors include Regal Funds Management, Biomedical Advanced Research and Development Authority (BARDA), Planet Innovation.
Lumos Diagnostics is headquartered in Carlsbad, United States.
Lumos Diagnostics provides point-of-care diagnostic solutions enabling healthcare professionals to diagnose conditions accurately.
Lumos Diagnostics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lumos Diagnostics — Funding & Investors." VCBacked, March 26, 2026, https://www.vcbacked.co/company/lumos-diagnostics. Accessed August 24, 2026.
VCBacked. (2026). Lumos Diagnostics — Funding & Investors. Retrieved August 24, 2026, from https://www.vcbacked.co/company/lumos-diagnostics
{{cite web |title=Lumos Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/lumos-diagnostics |website=VCBacked |access-date=August 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated